img

Global Finasteride Tablets Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Finasteride Tablets Market Research Report 2024

Finasteride, sold under the brand names Proscar and Propecia among others, is a medication used for the treatment of benign prostatic hyperplasia (BPH) and male pattern baldness (MPB).
According to Mr Accuracy reports new survey, global Finasteride Tablets market is projected to reach US$ 155.9 million in 2029, increasing from US$ 118.4 million in 2022, with the CAGR of 3.9% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Finasteride Tablets market research.
Key manufacturers engaged in the Finasteride Tablets industry include Merck, Actavis, Sandoz, Teva Pharmaceuticals, Cipla, RelonChem, Dr. Reddy, Accord Pharmaceuticals and Henan Topfond, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Finasteride Tablets were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Finasteride Tablets market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Finasteride Tablets market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Merck
Actavis
Sandoz
Teva Pharmaceuticals
Cipla
RelonChem
Dr. Reddy
Accord Pharmaceuticals
Henan Topfond
Zhejiang CONBA Pharmaceutical
Shandong Renhetang Pharmaceutical
Guangdong Eashu Pharmacetical
Segment by Type
1mg Tablet
5mg Tablet

Segment by Application


Benign Prostatic Hyperplasia
Male Pattern Baldness
Others

Consumption by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Finasteride Tablets report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Finasteride Tablets Market Overview
1.1 Product Overview and Scope of Finasteride Tablets
1.2 Finasteride Tablets Segment by Type
1.2.1 Global Finasteride Tablets Market Value Comparison by Type (2024-2034)
1.2.2 1mg Tablet
1.2.3 5mg Tablet
1.3 Finasteride Tablets Segment by Application
1.3.1 Global Finasteride Tablets Market Value by Application: (2024-2034)
1.3.2 Benign Prostatic Hyperplasia
1.3.3 Male Pattern Baldness
1.3.4 Others
1.4 Global Finasteride Tablets Market Size Estimates and Forecasts
1.4.1 Global Finasteride Tablets Revenue 2018-2029
1.4.2 Global Finasteride Tablets Sales 2018-2029
1.4.3 Global Finasteride Tablets Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Finasteride Tablets Market Competition by Manufacturers
2.1 Global Finasteride Tablets Sales Market Share by Manufacturers (2018-2024)
2.2 Global Finasteride Tablets Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Finasteride Tablets Average Price by Manufacturers (2018-2024)
2.4 Global Finasteride Tablets Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Finasteride Tablets, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Finasteride Tablets, Product Type & Application
2.7 Finasteride Tablets Market Competitive Situation and Trends
2.7.1 Finasteride Tablets Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Finasteride Tablets Players Market Share by Revenue
2.7.3 Global Finasteride Tablets Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Finasteride Tablets Retrospective Market Scenario by Region
3.1 Global Finasteride Tablets Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Finasteride Tablets Global Finasteride Tablets Sales by Region: 2018-2029
3.2.1 Global Finasteride Tablets Sales by Region: 2018-2024
3.2.2 Global Finasteride Tablets Sales by Region: 2024-2029
3.3 Global Finasteride Tablets Global Finasteride Tablets Revenue by Region: 2018-2029
3.3.1 Global Finasteride Tablets Revenue by Region: 2018-2024
3.3.2 Global Finasteride Tablets Revenue by Region: 2024-2029
3.4 North America Finasteride Tablets Market Facts & Figures by Country
3.4.1 North America Finasteride Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Finasteride Tablets Sales by Country (2018-2029)
3.4.3 North America Finasteride Tablets Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Finasteride Tablets Market Facts & Figures by Country
3.5.1 Europe Finasteride Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Finasteride Tablets Sales by Country (2018-2029)
3.5.3 Europe Finasteride Tablets Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Finasteride Tablets Market Facts & Figures by Country
3.6.1 Asia Pacific Finasteride Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Finasteride Tablets Sales by Country (2018-2029)
3.6.3 Asia Pacific Finasteride Tablets Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Finasteride Tablets Market Facts & Figures by Country
3.7.1 Latin America Finasteride Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Finasteride Tablets Sales by Country (2018-2029)
3.7.3 Latin America Finasteride Tablets Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Finasteride Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Finasteride Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Finasteride Tablets Sales by Country (2018-2029)
3.8.3 Middle East and Africa Finasteride Tablets Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Finasteride Tablets Sales by Type (2018-2029)
4.1.1 Global Finasteride Tablets Sales by Type (2018-2024)
4.1.2 Global Finasteride Tablets Sales by Type (2024-2029)
4.1.3 Global Finasteride Tablets Sales Market Share by Type (2018-2029)
4.2 Global Finasteride Tablets Revenue by Type (2018-2029)
4.2.1 Global Finasteride Tablets Revenue by Type (2018-2024)
4.2.2 Global Finasteride Tablets Revenue by Type (2024-2029)
4.2.3 Global Finasteride Tablets Revenue Market Share by Type (2018-2029)
4.3 Global Finasteride Tablets Price by Type (2018-2029)
5 Segment by Application
5.1 Global Finasteride Tablets Sales by Application (2018-2029)
5.1.1 Global Finasteride Tablets Sales by Application (2018-2024)
5.1.2 Global Finasteride Tablets Sales by Application (2024-2029)
5.1.3 Global Finasteride Tablets Sales Market Share by Application (2018-2029)
5.2 Global Finasteride Tablets Revenue by Application (2018-2029)
5.2.1 Global Finasteride Tablets Revenue by Application (2018-2024)
5.2.2 Global Finasteride Tablets Revenue by Application (2024-2029)
5.2.3 Global Finasteride Tablets Revenue Market Share by Application (2018-2029)
5.3 Global Finasteride Tablets Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Finasteride Tablets Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Merck Finasteride Tablets Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Actavis
6.2.1 Actavis Corporation Information
6.2.2 Actavis Description and Business Overview
6.2.3 Actavis Finasteride Tablets Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Actavis Finasteride Tablets Product Portfolio
6.2.5 Actavis Recent Developments/Updates
6.3 Sandoz
6.3.1 Sandoz Corporation Information
6.3.2 Sandoz Description and Business Overview
6.3.3 Sandoz Finasteride Tablets Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Sandoz Finasteride Tablets Product Portfolio
6.3.5 Sandoz Recent Developments/Updates
6.4 Teva Pharmaceuticals
6.4.1 Teva Pharmaceuticals Corporation Information
6.4.2 Teva Pharmaceuticals Description and Business Overview
6.4.3 Teva Pharmaceuticals Finasteride Tablets Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Teva Pharmaceuticals Finasteride Tablets Product Portfolio
6.4.5 Teva Pharmaceuticals Recent Developments/Updates
6.5 Cipla
6.5.1 Cipla Corporation Information
6.5.2 Cipla Description and Business Overview
6.5.3 Cipla Finasteride Tablets Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Cipla Finasteride Tablets Product Portfolio
6.5.5 Cipla Recent Developments/Updates
6.6 RelonChem
6.6.1 RelonChem Corporation Information
6.6.2 RelonChem Description and Business Overview
6.6.3 RelonChem Finasteride Tablets Sales, Revenue and Gross Margin (2018-2024)
6.6.4 RelonChem Finasteride Tablets Product Portfolio
6.6.5 RelonChem Recent Developments/Updates
6.7 Dr. Reddy
6.6.1 Dr. Reddy Corporation Information
6.6.2 Dr. Reddy Description and Business Overview
6.6.3 Dr. Reddy Finasteride Tablets Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Dr. Reddy Finasteride Tablets Product Portfolio
6.7.5 Dr. Reddy Recent Developments/Updates
6.8 Accord Pharmaceuticals
6.8.1 Accord Pharmaceuticals Corporation Information
6.8.2 Accord Pharmaceuticals Description and Business Overview
6.8.3 Accord Pharmaceuticals Finasteride Tablets Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Accord Pharmaceuticals Finasteride Tablets Product Portfolio
6.8.5 Accord Pharmaceuticals Recent Developments/Updates
6.9 Henan Topfond
6.9.1 Henan Topfond Corporation Information
6.9.2 Henan Topfond Description and Business Overview
6.9.3 Henan Topfond Finasteride Tablets Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Henan Topfond Finasteride Tablets Product Portfolio
6.9.5 Henan Topfond Recent Developments/Updates
6.10 Zhejiang CONBA Pharmaceutical
6.10.1 Zhejiang CONBA Pharmaceutical Corporation Information
6.10.2 Zhejiang CONBA Pharmaceutical Description and Business Overview
6.10.3 Zhejiang CONBA Pharmaceutical Finasteride Tablets Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Zhejiang CONBA Pharmaceutical Finasteride Tablets Product Portfolio
6.10.5 Zhejiang CONBA Pharmaceutical Recent Developments/Updates
6.11 Shandong Renhetang Pharmaceutical
6.11.1 Shandong Renhetang Pharmaceutical Corporation Information
6.11.2 Shandong Renhetang Pharmaceutical Finasteride Tablets Description and Business Overview
6.11.3 Shandong Renhetang Pharmaceutical Finasteride Tablets Sales, Revenue and Gross Margin (2018-2024)
6.11.4 Shandong Renhetang Pharmaceutical Finasteride Tablets Product Portfolio
6.11.5 Shandong Renhetang Pharmaceutical Recent Developments/Updates
6.12 Guangdong Eashu Pharmacetical
6.12.1 Guangdong Eashu Pharmacetical Corporation Information
6.12.2 Guangdong Eashu Pharmacetical Finasteride Tablets Description and Business Overview
6.12.3 Guangdong Eashu Pharmacetical Finasteride Tablets Sales, Revenue and Gross Margin (2018-2024)
6.12.4 Guangdong Eashu Pharmacetical Finasteride Tablets Product Portfolio
6.12.5 Guangdong Eashu Pharmacetical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Finasteride Tablets Industry Chain Analysis
7.2 Finasteride Tablets Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Finasteride Tablets Production Mode & Process
7.4 Finasteride Tablets Sales and Marketing
7.4.1 Finasteride Tablets Sales Channels
7.4.2 Finasteride Tablets Distributors
7.5 Finasteride Tablets Customers
8 Finasteride Tablets Market Dynamics
8.1 Finasteride Tablets Industry Trends
8.2 Finasteride Tablets Market Drivers
8.3 Finasteride Tablets Market Challenges
8.4 Finasteride Tablets Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Finasteride Tablets Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Finasteride Tablets Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Finasteride Tablets Market Competitive Situation by Manufacturers in 2022
Table 4. Global Finasteride Tablets Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Finasteride Tablets Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Finasteride Tablets Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Finasteride Tablets Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Finasteride Tablets Average Price (USD/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Finasteride Tablets, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Finasteride Tablets, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Finasteride Tablets, Product Type & Application
Table 12. Global Key Manufacturers of Finasteride Tablets, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Finasteride Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Finasteride Tablets as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Finasteride Tablets Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Finasteride Tablets Sales by Region (2018-2024) & (K Units)
Table 18. Global Finasteride Tablets Sales Market Share by Region (2018-2024)
Table 19. Global Finasteride Tablets Sales by Region (2024-2029) & (K Units)
Table 20. Global Finasteride Tablets Sales Market Share by Region (2024-2029)
Table 21. Global Finasteride Tablets Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Finasteride Tablets Revenue Market Share by Region (2018-2024)
Table 23. Global Finasteride Tablets Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Finasteride Tablets Revenue Market Share by Region (2024-2029)
Table 25. North America Finasteride Tablets Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Finasteride Tablets Sales by Country (2018-2024) & (K Units)
Table 27. North America Finasteride Tablets Sales by Country (2024-2029) & (K Units)
Table 28. North America Finasteride Tablets Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Finasteride Tablets Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Finasteride Tablets Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Finasteride Tablets Sales by Country (2018-2024) & (K Units)
Table 32. Europe Finasteride Tablets Sales by Country (2024-2029) & (K Units)
Table 33. Europe Finasteride Tablets Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Finasteride Tablets Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Finasteride Tablets Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Finasteride Tablets Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Finasteride Tablets Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Finasteride Tablets Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Finasteride Tablets Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Finasteride Tablets Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Finasteride Tablets Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Finasteride Tablets Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Finasteride Tablets Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Finasteride Tablets Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Finasteride Tablets Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Finasteride Tablets Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Finasteride Tablets Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Finasteride Tablets Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Finasteride Tablets Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Finasteride Tablets Sales (K Units) by Type (2018-2024)
Table 51. Global Finasteride Tablets Sales (K Units) by Type (2024-2029)
Table 52. Global Finasteride Tablets Sales Market Share by Type (2018-2024)
Table 53. Global Finasteride Tablets Sales Market Share by Type (2024-2029)
Table 54. Global Finasteride Tablets Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Finasteride Tablets Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Finasteride Tablets Revenue Market Share by Type (2018-2024)
Table 57. Global Finasteride Tablets Revenue Market Share by Type (2024-2029)
Table 58. Global Finasteride Tablets Price (USD/Unit) by Type (2018-2024)
Table 59. Global Finasteride Tablets Price (USD/Unit) by Type (2024-2029)
Table 60. Global Finasteride Tablets Sales (K Units) by Application (2018-2024)
Table 61. Global Finasteride Tablets Sales (K Units) by Application (2024-2029)
Table 62. Global Finasteride Tablets Sales Market Share by Application (2018-2024)
Table 63. Global Finasteride Tablets Sales Market Share by Application (2024-2029)
Table 64. Global Finasteride Tablets Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Finasteride Tablets Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Finasteride Tablets Revenue Market Share by Application (2018-2024)
Table 67. Global Finasteride Tablets Revenue Market Share by Application (2024-2029)
Table 68. Global Finasteride Tablets Price (USD/Unit) by Application (2018-2024)
Table 69. Global Finasteride Tablets Price (USD/Unit) by Application (2024-2029)
Table 70. Merck Corporation Information
Table 71. Merck Description and Business Overview
Table 72. Merck Finasteride Tablets Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 73. Merck Finasteride Tablets Product
Table 74. Merck Recent Developments/Updates
Table 75. Actavis Corporation Information
Table 76. Actavis Description and Business Overview
Table 77. Actavis Finasteride Tablets Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 78. Actavis Finasteride Tablets Product
Table 79. Actavis Recent Developments/Updates
Table 80. Sandoz Corporation Information
Table 81. Sandoz Description and Business Overview
Table 82. Sandoz Finasteride Tablets Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 83. Sandoz Finasteride Tablets Product
Table 84. Sandoz Recent Developments/Updates
Table 85. Teva Pharmaceuticals Corporation Information
Table 86. Teva Pharmaceuticals Description and Business Overview
Table 87. Teva Pharmaceuticals Finasteride Tablets Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 88. Teva Pharmaceuticals Finasteride Tablets Product
Table 89. Teva Pharmaceuticals Recent Developments/Updates
Table 90. Cipla Corporation Information
Table 91. Cipla Description and Business Overview
Table 92. Cipla Finasteride Tablets Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 93. Cipla Finasteride Tablets Product
Table 94. Cipla Recent Developments/Updates
Table 95. RelonChem Corporation Information
Table 96. RelonChem Description and Business Overview
Table 97. RelonChem Finasteride Tablets Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 98. RelonChem Finasteride Tablets Product
Table 99. RelonChem Recent Developments/Updates
Table 100. Dr. Reddy Corporation Information
Table 101. Dr. Reddy Description and Business Overview
Table 102. Dr. Reddy Finasteride Tablets Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 103. Dr. Reddy Finasteride Tablets Product
Table 104. Dr. Reddy Recent Developments/Updates
Table 105. Accord Pharmaceuticals Corporation Information
Table 106. Accord Pharmaceuticals Description and Business Overview
Table 107. Accord Pharmaceuticals Finasteride Tablets Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 108. Accord Pharmaceuticals Finasteride Tablets Product
Table 109. Accord Pharmaceuticals Recent Developments/Updates
Table 110. Henan Topfond Corporation Information
Table 111. Henan Topfond Description and Business Overview
Table 112. Henan Topfond Finasteride Tablets Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 113. Henan Topfond Finasteride Tablets Product
Table 114. Henan Topfond Recent Developments/Updates
Table 115. Zhejiang CONBA Pharmaceutical Corporation Information
Table 116. Zhejiang CONBA Pharmaceutical Description and Business Overview
Table 117. Zhejiang CONBA Pharmaceutical Finasteride Tablets Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 118. Zhejiang CONBA Pharmaceutical Finasteride Tablets Product
Table 119. Zhejiang CONBA Pharmaceutical Recent Developments/Updates
Table 120. Shandong Renhetang Pharmaceutical Corporation Information
Table 121. Shandong Renhetang Pharmaceutical Description and Business Overview
Table 122. Shandong Renhetang Pharmaceutical Finasteride Tablets Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 123. Shandong Renhetang Pharmaceutical Finasteride Tablets Product
Table 124. Shandong Renhetang Pharmaceutical Recent Developments/Updates
Table 125. Guangdong Eashu Pharmacetical Corporation Information
Table 126. Guangdong Eashu Pharmacetical Description and Business Overview
Table 127. Guangdong Eashu Pharmacetical Finasteride Tablets Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 128. Guangdong Eashu Pharmacetical Finasteride Tablets Product
Table 129. Guangdong Eashu Pharmacetical Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Finasteride Tablets Distributors List
Table 133. Finasteride Tablets Customers List
Table 134. Finasteride Tablets Market Trends
Table 135. Finasteride Tablets Market Drivers
Table 136. Finasteride Tablets Market Challenges
Table 137. Finasteride Tablets Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Finasteride Tablets
Figure 2. Global Finasteride Tablets Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Finasteride Tablets Market Share by Type in 2022 & 2029
Figure 4. 1mg Tablet Product Picture
Figure 5. 5mg Tablet Product Picture
Figure 6. Global Finasteride Tablets Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Finasteride Tablets Market Share by Application in 2022 & 2029
Figure 8. Benign Prostatic Hyperplasia
Figure 9. Male Pattern Baldness
Figure 10. Others
Figure 11. Global Finasteride Tablets Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Finasteride Tablets Market Size (2018-2029) & (US$ Million)
Figure 13. Global Finasteride Tablets Sales (2018-2029) & (K Units)
Figure 14. Global Finasteride Tablets Average Price (USD/Unit) & (2018-2029)
Figure 15. Finasteride Tablets Report Years Considered
Figure 16. Finasteride Tablets Sales Share by Manufacturers in 2022
Figure 17. Global Finasteride Tablets Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Finasteride Tablets Players: Market Share by Revenue in 2022
Figure 19. Finasteride Tablets Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Finasteride Tablets Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. North America Finasteride Tablets Sales Market Share by Country (2018-2029)
Figure 22. North America Finasteride Tablets Revenue Market Share by Country (2018-2029)
Figure 23. U.S. Finasteride Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Canada Finasteride Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Europe Finasteride Tablets Sales Market Share by Country (2018-2029)
Figure 26. Europe Finasteride Tablets Revenue Market Share by Country (2018-2029)
Figure 27. Germany Finasteride Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. France Finasteride Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. U.K. Finasteride Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Italy Finasteride Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Russia Finasteride Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Asia Pacific Finasteride Tablets Sales Market Share by Region (2018-2029)
Figure 33. Asia Pacific Finasteride Tablets Revenue Market Share by Region (2018-2029)
Figure 34. China Finasteride Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Japan Finasteride Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. South Korea Finasteride Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. India Finasteride Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Australia Finasteride Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Taiwan Finasteride Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Indonesia Finasteride Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Thailand Finasteride Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Malaysia Finasteride Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Philippines Finasteride Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Latin America Finasteride Tablets Sales Market Share by Country (2018-2029)
Figure 45. Latin America Finasteride Tablets Revenue Market Share by Country (2018-2029)
Figure 46. Mexico Finasteride Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Brazil Finasteride Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Argentina Finasteride Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Middle East & Africa Finasteride Tablets Sales Market Share by Country (2018-2029)
Figure 50. Middle East & Africa Finasteride Tablets Revenue Market Share by Country (2018-2029)
Figure 51. Turkey Finasteride Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Saudi Arabia Finasteride Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. UAE Finasteride Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Global Sales Market Share of Finasteride Tablets by Type (2018-2029)
Figure 55. Global Revenue Market Share of Finasteride Tablets by Type (2018-2029)
Figure 56. Global Finasteride Tablets Price (USD/Unit) by Type (2018-2029)
Figure 57. Global Sales Market Share of Finasteride Tablets by Application (2018-2029)
Figure 58. Global Revenue Market Share of Finasteride Tablets by Application (2018-2029)
Figure 59. Global Finasteride Tablets Price (USD/Unit) by Application (2018-2029)
Figure 60. Finasteride Tablets Value Chain
Figure 61. Finasteride Tablets Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed